Trial · NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
NCT06585787, Phase 3, Recruiting, Karuna Therapeutics, Inc., a Bristol Myers Squibb company
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4). Trials, record NCT06585787. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06585787
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- NCT number
- NCT06585787
- Status
- Recruiting
- Phases
- Phase 3
- Enrollment
- 406 participants, estimated
- Lead sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Conditions
- Alzheimer Disease
- Interventions
- KarXT, Placebo
- First posted
- 2024-09-19
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in Neuropsychiatric Inventory-Clinician: Hallucinations and Delusions (NPI-C: H+D) score | Up to Week 14 | |
| Secondary | Change from baseline in Clinical Global Impressions-Severity (CGI-S) scale | Up to Week 14 | |
| Secondary | Change from baseline in Neuropsychiatric Inventory-Clinician (NPI-C) Core score: Hallucination Domain | Up to Week 14 | |
| Secondary | Change from baseline in NPI-C Core score: Delusion Domain | Up to Week 14 | |
| Secondary | Change from baseline in NPI-C Core score: Agitation Domain | Up to Week 14 | |
| Secondary | Change from baseline in NPI-C Core score: Aggression Domain | Up to Week 14 | |
| Secondary | Change from baseline in NPI-C Agitation score | Up to Week 14 | |
| Secondary | Change from baseline in NPI-C Core score: Caregiver Distress Scale | Up to Week 14 | |
| Secondary | Number of participants with a ≥ 40% improvement from Baseline in NPI-C: H+D score | Up to Week 14 | |
| Secondary | Number of participants with Adverse Events (AEs) | Up to Week 14 |
1 to 10 of 27Source ClinicalTrials.gov
See all 27 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06585787
GET https://conductscience.org/api/trials/v1/NCT06585787/registered?page=2